Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Liver transplantation is proposed as the best therapy for early hepatocellular carcinoma in cirrhotic patients. However, the confrontation with the results obtained by surgical resection has never been done on an intention-to-treat basis. Between 1989 and 1997, 164 out of 1,265 patients with hepatocellular carcinoma were evaluated for surgery. Seventy-seven (48 men, mean 61 years of age, 74 Child-Pugh class A, size 33 ± 18 mm) were resected (first line option) and 87 (65 men, mean 55 years of age, 50 Child-Pugh class B/C, size 24 ± 14 mm) were selected for transplantation. The 1-, 3-, and 5-year “intention-to-treat” survival was 85%, 62%, and 51% for resection and 84%, 69%, and 69% for transplantation (8 drop-outs on waiting list). Bilirubin and clinically relevant portal hypertension were independent survival predictors after resection. Thereby, the 5-year survival of the best candidates (absence of clinically relevant portal hypertension, n = 35) was 74%, whereas it was 25% for the worst candidates (portal hypertension and bilirubin ≥1 mg/dL, n = 27) (P < .00001). The variable “drop-out on waiting list” was the sole survival predictor after transplantation. The 2-year survival rate of patients evaluated for transplantation was 84% in the 1989 to 1995 period (mean waiting time, 62 days; no drop-outs) and 54% during 1996 to 1997 (mean waiting time, 162 days; 8 drop-outs)(P < .003). This outcome was significantly lower than that of the best candidates for resection (P = .002). In conclusion, a proper selection of candidates for resection promotes better results than transplantation, in which the results are significantly hampered by the growing incidence of drop-outs because of the increasing waiting time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Llovet, J. M., Bustamante, J., Castells, A., Vilana, R., Del Carmen Ayuso, M., Sala, M., Brú, C., Rodés, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510290145 · Cited by 1,190
Self-citationLivraghi, T., Giorgio, A., Marin, G., Salmi, A., de Sio, I., Bolondi, L., Pompili, M., Brunello, F., Lazzaroni, S., & Torzilli, G. (1995) · Radiology · doi:10.1148/radiology.197.1.7568806 · Cited by 939
Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J., Visa, J., Bru, C., & Rodes, J. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70070-7 · Cited by 895
Self-citationLiver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients
Bismuth, H., Chiche, L., Adam, R., Castaing, D., Diamond, T., & Dennison, A. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00005 · Cited by 865
International Union Against Cancer (UICC)
Turner, B. (2012) · The Statesman’s Yearbook · doi:10.1007/978-1-349-59541-9_43 · Cited by 720
Hepatic Resection Versus Transplantation for Hepatocellular Carcinoma
IWATSUKI, S., STARZL, T. E., SHEAHAN, D. G., YOKOYAMA, I., DEMETRIS, A. J., TODO, S., TZAKIS, A. G., VAN THIEL, D. H., CARR, B., SELBY, R., et al. (1991) · Annals of Surgery · doi:10.1097/00000658-199109000-00005 · Cited by 669
Ringe, B., Pichlmayr, R., Wittekind, C., & Tusch, G. (1991) · World Journal of Surgery · doi:10.1007/bf01659064 · Cited by 565
Cited by
Items 101–123 of 123
Cabrera, R. (2012) · Hepatic Medicine: Evidence and Research · doi:10.2147/hmer.s16316 · Cited by 274
Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy
Wiesner, R. H., Freeman, R. B., & Mulligan, D. C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.040 · Cited by 273
Yu, S. J. (2016) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2016.22.1.7 · Cited by 273
Yao, F. Y., Bass, N. M., Nikolai, B., Merriman, R., Davern, T. J., Kerlan, R., Ascher, N. L., & Roberts, J. P. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50147 · Cited by 271
Improving liver allocation: MELD and PELD
Freeman, R. B., Wiesner, R. H., Roberts, J. P., McDiarmid, S., Dykstra, D. M., & Merion, R. M. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6135.2004.00403.x · Cited by 270
Sarasin, F. P., Majno, P. E., Llovet, J. M., Bruix, J., Mentha, G., & Hadengue, A. (2001) · Hepatology · doi:10.1053/jhep.2001.23311 · Cited by 263
Self-citationStrategies for the management of hepatocellular carcinoma
Schwartz, M., Roayaie, S., & Konstadoulakis, M. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0844 · Cited by 261
Practice guidelines for management of hepatocellular carcinoma 2009
Korean Liver Cancer Study Group and National Cancer Center, K. (2009) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2009.15.3.391 · Cited by 257
Orlando, A., Leandro, G., Olivo, M., Andriulli, A., & Cottone, M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.80 · Cited by 257
Tiong, L., & Maddern, G. J. (2011) · British Journal of Surgery · doi:10.1002/bjs.7669 · Cited by 253
Arguedas, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)06049-5 · Cited by 252
Hepatocellular carcinoma: present status and future prospects
Llovet, J. M., & Beaugrand, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00432-4 · Cited by 248
“Tumour recurrence complicates 50% of cases at 3 years, and deteriorates long-term survival [34,35].”
BackgroundInfluentialSelf-citationVibert, E., Azoulay, D., Hoti, E., Iacopinelli, S., Samuel, D., Salloum, C., Lemoine, A., Bismuth, H., Castaing, D., & Adam, R. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02750.x · Cited by 248
“In an intent-to-treat study, a high rate of AFP was also associated with a higher drop-out rate from LT waiting list (29,30).”
BackgroundPredictors of Long-Term Survival After Liver Transplantation for Hepatocellular Carcinoma
Zavaglia, C., De Carlis, L., Alberti, A. B., Minola, E., Belli, L. S., Slim, A. O., Airoldi, A., Giacomoni, A., Rondinara, G., Tinelli, C., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00289.x · Cited by 242
“However, the shortage of donors increases the waiting times to transplantation, facilitating tumor progression and dropouts while waiting, factors that might contribute to a poorer long-term survival of transplanted patients”
BackgroundGilles, H., Garbutt, T., & Landrum, J. (2022) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2022.04.004 · Cited by 224
Review article: the management of hepatocellular carcinoma
CABRERA, R., & NELSON, D. R. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04200.x · Cited by 222
Korean Liver Cancer Study Group (KLCSG), & National Cancer Center, K. (. (2015) · Korean Journal of Radiology · doi:10.3348/kjr.2015.16.3.465 · Cited by 201
“The 5-year recurrence rate following hepatic resection is up to 70% and is due to intrahepatic metastases and/or de novo carcinogenesis (96, 423, 499, 500).”
BackgroundSeo, S., Hatano, E., Higashi, T., Hara, T., Tada, M., Tamaki, N., Iwaisako, K., Ikai, I., & Uemoto, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1357 · Cited by 191
Poon, R. T. P., Fan, S. T., Lo, C. M., Liu, C. L., & Wong, J. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000225255.01668.65 · Cited by 171
“Most of the patients in the transplantation group had Child-Pugh class B or C cirrhosis, and they were more likely to be already under the care of physicians with regular surveillance for HCC, whereas Child-Pugh class A patients were less likely to have regular surveillance because they were asymptomatic before the de…”
MethodResultInfluentialYao, F. Y., Kinkhabwala, M., LaBerge, J. M., Bass, N. M., Brown, R., Kerlen, R., Venook, A., Ascher, N. L., Emond, J. C., & Roberts, J. P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00750.x · Cited by 170
Xu, W., Cao, L., Chen, L., Li, J., Zhang, X.-F., Qian, H.-H., Kang, X.-Y., Zhang, Y., Liao, J., Shi, L.-H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0498 · Cited by 161
“Tumor size, cm <3 24 9 11 12 16 (67) 5 (21) 10 (42) 1 (4) 3–5 34 17 19 19 28 (82) 9 (26) 13 (38) 6 (18) 5 27 31 33 19 25 (93) 4 (15) 10 (37) 11 (41) Portal vein tumor thrombus Without 36 4 6 4 24 (67) 13 (36) 10 (28) 1 (3) With 49 30 27 26 45 (92) 5 (10) 23 (47) 17 (35) Edmondson–Steiner grade I or II 22 8 12 8 13 (59…”
BackgroundPrimavesi, F., Maglione, M., Cipriani, F., Denecke, T., Oberkofler, C. E., Starlinger, P., Dasari, B. V. M., Heil, J., Sgarbura, O., Søreide, K., et al. (2023) · British Journal of Surgery · doi:10.1093/bjs/znad233 · Cited by 97
de Haas, R. J., Lim, C., Bhangui, P., Salloum, C., Compagnon, P., Feray, C., Calderaro, J., Luciani, A., & Azoulay, D. (2018) · Hepatology · doi:10.1002/hep.29468 · Cited by 65
“Median AST level, IU/L (IQR) 44 (27-69) 44 (25-77) 43 (30-63) 0.”
Result
Metadata
- Authors
- Llovet, J. M., Fuster, J., & Bruix, J.
- Venue
- Hepatology
- Published
- 1999-12
- Volume
- 30
- Issue
- 6
- Pages
- 1434-1440
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2060050131
- Cited by
- 1,708
- References
- 33
- FWCI
- 20.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.